Evidence map›Paper›PMID 42279320›Full record

ReviewCancers2026

Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework.

Ismaell Massalha, Adham Hijab, Reem Zabit, Bilal Krayim, Wael Hozaeel, Moatz Safadi, Samer Hussany, Israel Sandler, Jamal Zidan, Ofir Cohen and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ismaell MassalhaDepartment of Radiation Oncology, Ziv Medical Center, Safed 1300000, Israel.ORCID 0000-0001-7715-1825
Adham HijabDepartment of Radiation Oncology, Ziv Medical Center, Safed 1300000, Israel.
Reem ZabitDepartment of Pediatrics, Ziv Medical Center, Safed 1300000, Israel.
Bilal KrayimHelmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Wael HozaeelLegacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka University Medical Center, Beer Sheva 8410101, Israel.
Moatz SafadiDepartment of Oncology, Ziv Medical Center, Safed 1300000, Israel.
Samer HussanyLegacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka University Medical Center, Beer Sheva 8410101, Israel.
Israel SandlerDepartment of Nuclear Medicine, Ziv Medical Center, Safed 1300000, Israel.
Jamal ZidanDepartment of Oncology, Ziv Medical Center, Safed 1300000, Israel.
Ofir CohenFaculty of Health Sciences, Ben-Gurion University, Beer Sheva 8410501, Israel.
Ory WieselBaruch Padeh-Tzafon Medical Center, Poriya 1528001, Israel.ORCID 0000-0001-5304-7425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant nivolumabcervical esophageal canceresophagectomylarynx preservationneoadjuvant chemoimmunotherapypathologic complete responsepatient selection frameworkPRISMA systematic reviewsurgical timing

Identifiers

PMID42279320
PMCPMC13255703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.